R Andrew Eckert

R Andrew Eckert is a seasoned technology executive with an extensive background in health IT. They served as CEO and President at Eclipsys Corporation and ADAC Laboratories, leading the latter to a successful acquisition by Philips Medical Systems for $400 million. Eckert held various CEO roles at TriZetto Corporation and Valence Health, both of which were also successfully acquired. Currently, they are a Senior Advisor at Permira, an Executive Chairman at Kipu Health, and a member of the Board of Directors for multiple organizations, including BD and Vantive. They are pursuing an MBA and hold a BS in Industrial Engineering from Stanford University.